Discover how MedPharm’s end-to-end CDMO model supports topical semisolid and liquid drug development from early-stage formulation through commercial manufacturing. Explore how integrating formulation development, IVRT/IVPT testing, analytical services, stability studies, and GMP manufacturing within one organization helps maintain scientific continuity, reduce development risks, and streamline the path to commercialization. Read Blog →

Formulation challenges are a major but often overlooked source of development delays, clinical setbacks, and increased costs. For complex delivery routes, formulation optimization is critical to product performance, manufacturability, and long-term commercial success. In this blog, MedPharm explores the impact of formulation risk, common causes of formulation failure, and why a systematic, route-specific development strategy […]

This article explores the challenges and opportunities of nasal drug delivery, including formulation strategies, biological barriers, and targeting approaches for local and systemic therapies. It also highlights MedPharm’s expertise in preformulation, characterization, and advanced nasal models designed to support successful product development

This blog explores the challenges and opportunities of nasal drug delivery, including formulation strategies, biological barriers, and targeting approaches for local and systemic therapies. It also highlights MedPharm’s expertise in preformulation, characterization, and advanced nasal models designed to support successful product development

The global cosmetics market is growing rapidly, driven by consumer demand, social media influence, and interest in science-backed, personalized skincare. As scrutiny of product claims increases, advanced testing is becoming essential. This article highlights the evolving landscape of cosmetic testing and how MedPharm’s Center for Skin Biology supports robust, evidence-based claims.

This case study shows how MedPharm demonstrated the clinical efficacy and tolerability of MedSpray® in a non-inferiority study against a marketed antifungal treatment. Building on strong preclinical performance, the optimized MedSpray® formulation delivered equivalent antifungal activity while improving tolerability and maintaining comparable recurrence rates. These results confirm that enhanced topical drug delivery can translate into […]

This case study shows how MedPharm improved topical and transdermal drug delivery performance using MedSpray® film-forming technology. By optimizing formulation design and comparing performance against marketed patches, gels, and creams, MedSpray® demonstrated higher drug permeation, improved release profiles, and greater formulation flexibility.

This case study shows how MedPharm improved topical and transdermal drug delivery using its MedSpray® film-forming technology. By combining thermodynamically optimized formulations with an aerosol-based delivery system, MedSpray® enhanced drug permeation through the skin, increased tissue retention, and enabled both immediate and sustained release profiles. The result was improved formulation performance, better patient usability, and […]

This case study shows how MedPharm improved IVPT performance using MedFlux-HT®, an automated flow-through diffusion system. By maintaining optimal sink conditions and increasing sensitivity, MedFlux-HT® generated more reliable permeation data and enabled better formulation decisions.

This case study shows how MedPharm optimized skin explant models to improve stability and extend tissue viability for inflammation and wound healing studies. By preserving physiological relevance and enabling multi-endpoint analysis, the model generated more predictive data and supported better development decisions.